Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225966 · ClinicalTrials.gov registry record · NA
Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control
A NA study, sponsored by MedtronicNeuro.
- Terminated
- Registry status
- NA
- Development phase
- 153
- Enrollment target
NCT00225966 is a NA study that was terminated before completion, run by MedtronicNeuro. The registered enrollment target is 153 participants.
The verdict
NCT00225966, a NA study, was terminated before completion, sponsored by MedtronicNeuro.
- TERMINATED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
Study Summary
The purpose of this study is assess the long-term safety and effectiveness of the InterStim tined lead using a minimally invasive approach.
Interventions
- DEVICE Device Medtronic InterStim Tined Leads Models 3889 and 3093
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00225966
The ClinicalTrials.gov registry entry for NCT00225966 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MedtronicNeuro, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Device Medtronic InterStim Tined Leads Models 3889 and 3093 is the first listed.
NCT00225966 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00225966 about?
NCT00225966 is a clinical study titled "Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control". The purpose of this study is assess the long-term safety and effectiveness of the InterStim tined lead using a minimally invasive approach.
What is the current status of trial NCT00225966?
This trial is currently terminated. It is a NA study. The enrollment target is 153 participants. The study started on 2004-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00225966?
The interventions under investigation include: Device Medtronic InterStim Tined Leads Models 3889 and 3093 (DEVICE).
Who is sponsoring clinical trial NCT00225966?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.